Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Troublesome Signs for Bio/Pharmaceutical R&D

A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.
Dec 2, 2011

A dearth of late-stage candidates could hurt the pharmaceutical services market in the future.

Preparing for the Last War

CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
Nov 9, 2011

CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.

The EU Debt Crisis and CMOs

The EU debt crisis portends of possible negative repercussions for the dose CMO industry.
Oct 5, 2011

The EU debt crisis portends of possible negative repercussions for the dose CMO industry.

Preparing for the Last War

CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
Oct 2, 2011

CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.

The EU Debt Crisis and CMOs

The EU debt crisis portends of possible negative repercussions for the dose CMO industry.
Sep 2, 2011

The EU debt crisis portends of possible negative repercussions for the dose CMO industry.

Healthy Outlook for Pharma Services

Respondents to the 2011 PharmSource-Pharmaceutical Technology Outsourcing Survey paint a positive picture, but concerns linger under the surface. This article is part of a special issue on Outsourcing.
Aug 1, 2011

Respondents to the 2011 PharmSource-Pharmaceutical Technology Outsourcing Survey paint a positive picture, but concerns linger under the surface. This article is part of a special issue on Outsourcing.

Supply Chain Pain

Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.
Jun 2, 2011

Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.

Supply Chain Pain

Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.
May 2, 2011

Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.

A First Hand Look at India's Pharma Services Sector

Indian manufacturers are not a near-term threat to Western CMOs, but may be long term.
Apr 6, 2011

Indian manufacturers are not a near-term threat to Western CMOs, but may be long term.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
33%
Breakthrough designations
17%
Protecting the supply chain
50%
Expedited reviews of drug submissions
0%
More stakeholder involvement
0%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here